Thomas Wittig

500 total citations
23 papers, 315 citations indexed

About

Thomas Wittig is a scholar working on Pulmonary and Respiratory Medicine, Ecology and Organic Chemistry. According to data from OpenAlex, Thomas Wittig has authored 23 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Ecology and 3 papers in Organic Chemistry. Recurrent topics in Thomas Wittig's work include Respiratory and Cough-Related Research (6 papers), Avian ecology and behavior (4 papers) and Pediatric health and respiratory diseases (3 papers). Thomas Wittig is often cited by papers focused on Respiratory and Cough-Related Research (6 papers), Avian ecology and behavior (4 papers) and Pediatric health and respiratory diseases (3 papers). Thomas Wittig collaborates with scholars based in Germany, United States and Switzerland. Thomas Wittig's co-authors include Christian de Mey, Nicolette L. Cagle, R. Scott Winton, Natalia Ocampo‐Peñuela, H Matthys, Jochen Lehmann, Michael Decker, Bryan M. Kluever, Eugen J. Verspohl and Wolfgang Sadée and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Journal of Medical Internet Research.

In The Last Decade

Thomas Wittig

20 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Wittig Germany 10 74 65 38 35 33 23 315
Leszek Satora Poland 11 83 1.1× 72 1.1× 41 1.1× 23 0.7× 12 0.4× 39 343
Jerry D. Johnson United States 13 40 0.5× 58 0.9× 80 2.1× 14 0.4× 88 2.7× 38 452
J.W.G.M. Wilmer Netherlands 14 47 0.6× 38 0.6× 126 3.3× 4 0.1× 33 1.0× 26 542
Jayalakshmi Krishnan India 11 34 0.5× 16 0.2× 126 3.3× 14 0.4× 40 1.2× 21 489
M. Cerdá Spain 9 24 0.3× 61 0.9× 125 3.3× 8 0.2× 23 0.7× 19 350
Liling Liu China 10 57 0.8× 20 0.3× 111 2.9× 36 1.0× 9 0.3× 26 360
H. Hentschel Germany 12 114 1.5× 25 0.4× 175 4.6× 12 0.3× 24 0.7× 44 490
Hongjiao Cai China 11 12 0.2× 26 0.4× 80 2.1× 17 0.5× 20 0.6× 26 404
Elfride Balanza Bolivia 7 14 0.2× 35 0.5× 80 2.1× 25 0.7× 32 1.0× 10 431
Lena Jönsson Sweden 12 14 0.2× 36 0.6× 45 1.2× 5 0.1× 29 0.9× 22 467

Countries citing papers authored by Thomas Wittig

Since Specialization
Citations

This map shows the geographic impact of Thomas Wittig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Wittig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Wittig more than expected).

Fields of papers citing papers by Thomas Wittig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Wittig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Wittig. The network helps show where Thomas Wittig may publish in the future.

Co-authorship network of co-authors of Thomas Wittig

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Wittig. A scholar is included among the top collaborators of Thomas Wittig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Wittig. Thomas Wittig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dreher, Michael, Hans Erik Heier, J. Simon, et al.. (2025). Randomised, Placebo-Controlled, Double-Blind Trial to Assess Efficacy and Safety of ELOM-080 in Outpatients with COVID-19. Advances in Therapy. 42(2). 1237–1250.
2.
Wittig, Thomas, et al.. (2024). Continuous Improvement of Chronic Tinnitus Through a 9-Month Smartphone-Based Cognitive Behavioral Therapy: Randomized Controlled Trial. Journal of Medical Internet Research. 27. e59575–e59575. 2 indexed citations
3.
Gedir, Jay V., et al.. (2023). Nest Success of Bald Eagles Exposed to Anthropogenic Activities in the United States. Journal of Fish and Wildlife Management. 14(2). 283–293. 1 indexed citations
4.
Dreher, Michael, Christian Grohé, Niels‐Ulrik Korbinian Hartmann, et al.. (2022). Efficacy and Safety of ELOM-080 as Add-On Therapy in COVID-19 Patients with Acute Respiratory Insufficiency: Exploratory Data from the Prospective Placebo-Controlled COVARI Trial. Advances in Therapy. 39(6). 3011–3018. 1 indexed citations
5.
Pfaar, Oliver, Achim G. Beule, Karin Kraft, et al.. (2022). Phytomedicine ELOM‐080 in Acute Viral Rhinosinusitis: A Randomized, Placebo‐Controlled, Blinded Clinical Trial. The Laryngoscope. 133(7). 1576–1583. 2 indexed citations
6.
Wittig, Thomas. (2021). Mukoziliäre Clearance bei COVID-19-Erkrankungen. MMW - Fortschritte der Medizin. 163(S5). 21–27. 2 indexed citations
7.
Thomsen, Jørn Bo, et al.. (2021). Virucidal and virostatic in vitro activity of ELOM-080 against respiratory pathogens. Phytomedicine Plus. 1(3). 100035–100035. 2 indexed citations
8.
Lawall, Holger, et al.. (2020). Intermittent Administration of Nitroglycerin Sublingual Powder Compared with Placebo in Outpatients with Peripheral Artery Disease: Results of a Randomised Proof of Concept Study. European Journal of Vascular and Endovascular Surgery. 61(3). 457–465. 1 indexed citations
9.
Wittig, Thomas, et al.. (2020). An evaluation of bird and bat mortality at wind turbines in the Northeastern United States. PLoS ONE. 15(8). e0238034–e0238034. 20 indexed citations
10.
Fürst, Robert, et al.. (2019). ELOM-080 as Add-On Treatment for Respiratory Tract Diseases – A Review of Clinical Studies Conducted in China. Planta Medica. 85(09/10). 745–754. 12 indexed citations
11.
Wittig, Thomas, et al.. (2017). Species traits and local abundance affect bird-window collision frequency. Avian Conservation and Ecology. 12(1). 33 indexed citations
12.
13.
14.
Begrow, Frank, et al.. (2012). Effect of Myrtol Standardized and Other Substances on the Respiratory Tract: Ciliary Beat Frequency and Mucociliary Clearance as Parameters. Advances in Therapy. 29(4). 350–358. 28 indexed citations
15.
Wittig, Thomas, et al.. (2011). Efficacy and Tolerability of Myrtol Standardized in Long-term Treatment of Chronic Bronchitis. Arzneimittelforschung. 49(4). 351–358. 28 indexed citations
16.
Matthys, H, et al.. (2011). Efficacy and Tolerability of Myrtol Standardized in Acute Bronchitis. Arzneimittelforschung. 50(8). 700–711. 51 indexed citations
17.
18.
El‐Subbagh, Hussein I., Thomas Wittig, Michael Decker, et al.. (2002). Dopamine/Serotonin Receptor Ligands. Part IV [1]: Synthesis and Pharmacology of Novel 3-Benzazecines and 3-Benzazonines as Potential 5-HT2A and Dopamine Receptor Ligands. Archiv der Pharmazie. 335(9). 443–448. 21 indexed citations
19.
Botka, Christopher, Thomas Wittig, Carsten Uhd Nielsen, et al.. (2000). Human proton/oligopeptide transporter (POT) genes: Identification of putative human genes using bioinformatics. PubMed. 2(2). 76–97. 45 indexed citations
20.
Wittig, Thomas, et al.. (1996). [Torasemide in patients with chronic heart failure. Results of clinical administration in general practice].. PubMed. 114(3). 24–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leszek Satora Breakdown of academic impact, for papers by Jerry D. Johnson Breakdown of academic impact, for papers by J.W.G.M. Wilmer Breakdown of academic impact, for papers by Jayalakshmi Krishnan Breakdown of academic impact, for papers by M. Cerdá Breakdown of academic impact, for papers by Liling Liu Breakdown of academic impact, for papers by H. Hentschel Breakdown of academic impact, for papers by Hongjiao Cai Breakdown of academic impact, for papers by Elfride Balanza Breakdown of academic impact, for papers by Lena Jönsson
Rankless by CCL
2026